Sign up now and receive the HHMI Bulletin by mail free.
RESEARCH NEWSFROM HHMI
Mutant Mouse Mimics Human Bone Cancer
HHMI researchers have developed a mouse model of osteosarcoma, the most common form of bone cancer.
New Genetic Barcoding Technique Identifies Dozens of Targets for Cancer Drugs
HHMI investigators are beginning to examine every gene in the genome to figure out which genes are deleterious to tumor cells.
A Genetic "Gang of Four" Drives Spread of Breast Cancer
Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs.
Common Molecule Notifies Immune System of Prostate Cancer
In experiments with mice, researchers have found that the body’s immune system can use a surprisingly common molecule to recognize prostate tumors.
HHMI SCIENTISTS AND ANGIOGENESIS
D. Gary Gilliland
Todd R. Golub
Boris O. Kopnin
FROM THE HHMI BULLETIN
Putting the Brakes on Cancer (May 2007) By reactivating p53—a renowned tumor-suppressor gene—researchers are stopping even advanced cancers in mice.
Bringing Down Cancer's House of Cards(February 2008)
Defining an elaborate yet fragile control pathway offers a new strategy for toppling many cancers.
The Evolution of Cancer
Understanding Cancer Diversity
Subscribe to the HHMI Bulletin
Cover Story: I Am a Scientist
HHMI's EXROP program has helped hundreds of underrepresented minorities identify as researchers, a key step toward a science career.
A Structural Toolbox
No longer content with static snapshots, biologists are using a medley of techniques to get a global view of molecules at work.
The O'Shea Way
HHMI's new chief scientific officer Erin O'Shea applies an uncommon intensity to her research and training&151;of students and German shepherds.
About HHMI |
Press Room |